Veterinary Medicines

Amoxycol suspensão injectável para bovinos, suínos e cães

Authorised
  • Amoxicillin trihydrate
  • COLISTIN SULFATE
Download as PDF

Product identification

Medicine name:
Amoxycol suspensão injectável para bovinos, suínos e cães
Active substance:
  • Amoxicillin trihydrate
  • COLISTIN SULFATE
Target species:
  • Cattle
  • Pig
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • COLISTIN SULFATE
    250000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        36
        day
      • Milk
        3
        day
    • Pig
      • Meat and offal
        36
        day
    • Dog
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 51046
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 19/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."